Adaptation of wild-type rabies virus on vaccine producing cell line and its quantification by peroxidase-based immunostaining.

Authors

Muhammad Rehan Riaz, Syed Muhammad Kamran Ullah, Muhammad Rashid, Kaleem Ullah, Hamid Ahmad, Qari Muhammad Kaleem, Faiza Jamil, Saifullah Khan

Published in

Archives of virology. Volume 171. Issue 9. Aug 14, 2026. Epub Aug 14, 2026.

Abstract

Rabies lyssavirus, the causative agent of rabies (acute progressive encephalomyelitis) requires specific receptors on host cell to mediate neurotropism. Typically, cell lines used for rabies vaccine production are devoid of these receptors. In this study, we developed and optimized a protocol for adapting a locally isolated wild type rabies virus belonging to the Arctic-like lineage A1a, to a vaccine producing cell line, quantified its infectious titer using peroxidase-based immunostaining and virus neutralization was assessed using sera obtained from Abhayrab^®-vaccinated individuals. The virus was initially propagated in mouse neuroblastoma cell line and gradually adapted to replicate in Vero E6 by serial passages. The adaptation was confirmed by cytopathic effect and the viral titer rose to as high as 1.72 × 10⁷ FFU/mL. This is the first study to provide a detailed documentation of significant and typical cytopathic effect induced by an Arctic-like A1a lineage RABV in Vero E6 cells.

PMID:
42601531
Bibliographic data and abstract were imported from PubMed on 15 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.